![Julie Sosa: Clinically motivated NGS analysis suggests RETM918T may not portend the compromised outcomes expected](https://oncodaily.com/pub/uploads/2024/06/screnshot-11-1280x720.jpg)
Jun 13, 2024, 13:50
Julie Sosa: Clinically motivated NGS analysis suggests RETM918T may not portend the compromised outcomes expected
Julie Sosa, Chair of Department of Surgery at UCSF Health, shared on X/Twitter:
“Clinically motivated NGS analysis with a medullary thyroid CA registry from MD Anderson Cancer Center, UCSF Surgery suggests RETM918T may not portend the compromised outcomes expected. Thanks for the feature Endocrine Society, Endocrine Society Journals!”
Visit the article website.
Source: Julie Sosa/X